Uracil

-1.07

-1.07

3600

3.6 mg/mL

338

330 °C

Solid; [Merck Index] White powder; [Alfa Aesar MSDS]

Solid

Positive

0.68

2.7

Agilent XCT

Electrospray ionization

formic acid (5.3nM)

126.98 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]

115 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]

112.9 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

118.5 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

113.5 Ų [M-H]-；126.2 Ų [M+H]+

This chemical does not meet GHS hazard criteria for 82.4% (14 of 17) of all reports.

Warning

H315 (11.8%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (11.8%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H335 (11.8%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 17 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Reported as not meeting GHS hazard criteria per 14 of 17 reports by companies.；There are 3 notifications provided by 3 of 17 reports by companies with hazard statement code(s).；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Status: Active Update: 31-01-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/19811

2,4(1H,3H)-Pyrimidinedione: Does not have an individual approval but may be used under an appropriate group standard

Status: Active Update: 31-01-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/19811

2,4(1H,3H)-Pyrimidinedione: Does not have an individual approval but may be used under an appropriate group standard

Beta Ureidopropionase Deficiency；beta-Alanine metabolism；Carnosinuria, carnosinemia；Dihydropyrimidinase Deficiency；GABA-Transaminase Deficiency；MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)；Pyrimidine metabolism；UMP Synthase Deficiency (Orotic Aciduria)；Ureidopropionase Deficiency

Produced by hydrolysis of nucleic acids; Used in biochemical research; [Merck Index]

Use (kg; approx.) in Germany (2009): >10；Consumption (g per capita; approx.) in Germany (2009): 0.000122；Calculated removal (%): 75.1